 |
 |

Injection Drug Users in the United States, 1979-2002An Aging Population
Gregory L. Armstrong, MD
Arch Intern Med. 2007;167(2):166-173.
Background Injection drug use (IDU) is important in the epidemiology of blood-borne pathogens. Herein, trends in IDU from 1979 to 2002 are analyzed.
Methods The National Household Survey on Drug Abuse is an ongoing survey of drug use among the US population 12 years and older. Participants were chosen using a multistage sampling design and interviewed by written questionnaire (1979-1998) or audio computer-assisted self-interviewing (1999-2002). Herein, we examine the prevalence of a history of IDU at any time in the past (IDU-ever) or within the past year.
Results In the 2000-2002 surveys, 1.5% (95% confidence interval [CI], 1.4%-1.6%) reported IDU-ever (weighted estimate, 3.4 million persons). Prevalence was highest in persons aged 35 to 49 years (3.1%; 95% CI, 2.8%-3.4%), was higher in men (2.0%; 95% CI, 1.8%-2.2%) than women (1.0%; 95% CI, 0.9%-1.1%), and was higher in whites (1.7%; 95% CI, 1.5%-1.8%) than blacks (0.8%; 95% CI, 0.7%-1.1%) or Hispanics (1.1%; 95% CI, 0.8%-1.4%). Prevalence decreased with increasing annual income and educational level. Of all participants, 0.19% (95% CI, 0.16%-0.23%) reported IDU within the past year (weighted estimate, 440 000 persons). Ten years earlier (1990-1992), 1.6% (95% CI, 1.5%-1.8%) reported IDU-ever; prevalence did not differ by race. From 1979 through 2002, the mean age of participants with IDU within the past year increased from 21 to 36 years; the age of participants with IDU-ever increased from 26 to 42 years. From 2000 to 2002, 59.4% of all persons with IDU-ever were aged 35 to 49 years.
Conclusions The mean age of injection drug users has increased substantially. Persons born between the late 1940s and early 1960s have the highest prevalence of IDU-ever. Self-reported IDU rates are now lower among young blacks than young whites.
Author Affiliation: Division of Viral Hepatitis, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga.
RELATED LETTERS
Chronic Venous Disease and Injection Drug Use
Barbara Pieper, Robert S. Kirsner, Thomas N. Templin, and Thomas J. Birk
Arch Intern Med. 2007;167(16):1807.
EXTRACT
| FULL TEXT
Prisoners (Should) Count
Robert G. Newman
Arch Intern Med. 2007;167(16):1807.
EXTRACT
| FULL TEXT
Prisoners (Should) Count—Reply
Gregory L. Armstrong
Arch Intern Med. 2007;167(16):1807-1808.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Gender and Outcome in Adult Congenital Heart Disease
Verheugt et al.
Circulation 2008;118:26-32.
ABSTRACT
| FULL TEXT
Injection Drug Use: An Understudied Cause of Venous Disease
Pieper et al.
Arch Dermatol 2007;143:1305-1309.
ABSTRACT
| FULL TEXT
Chronic Venous Disease and Injection Drug Use
Pieper et al.
Arch Intern Med 2007;167:1807-1807.
FULL TEXT
Prisoners (Should) Count
Newman
Arch Intern Med 2007;167:1807-1807.
FULL TEXT
Prisoners (Should) Count Reply
Armstrong
Arch Intern Med 2007;167:1807-1808.
FULL TEXT
|